0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drugs for Anti-Infective Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-23M2579
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
COVID 19 Impact on Drugs for Anti Infective Market Global Research Reports 2020 2021
BUY CHAPTERS

Global Drugs for Anti-Infective Market Research Report 2024

Code: QYRE-Auto-23M2579
Report
January 2024
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Drugs for Anti-Infective Market Size

The global Drugs for Anti-Infective market was valued at US$ 215340 million in 2023 and is anticipated to reach US$ 272130 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.

Drugs for Anti-Infective Market

Drugs for Anti-Infective Market

Something capable of acting against infection, by inhibiting the spread of an infectious agent or by killing the infectious agent outright. Anti-infective is a general term that encompasses antibacterials, antibiotics, antifungals, antiprotozoans and antivirals.
The Anti-Infective Drugs market refers to the pharmaceuticals and medications used for the treatment of infectious diseases caused by bacteria, viruses, fungi, or parasites. This market encompasses various therapeutic areas such as antibiotics, antivirals, antifungals, and antiparasitics. The Anti-Infective Drugs market has been witnessing steady growth due to factors such as the increasing prevalence of infectious diseases, the emergence of drug-resistant strains, and the growing global population. Key players in the market include pharmaceutical companies, biotechnology firms, and generic drug manufacturers. Geographically, North America currently holds a significant market share, but the market in Asia Pacific is expected to witness substantial growth in the coming years.
This report aims to provide a comprehensive presentation of the global market for Drugs for Anti-Infective, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Anti-Infective.

Report Scope

The Drugs for Anti-Infective market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drugs for Anti-Infective market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drugs for Anti-Infective companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Drugs for Anti-Infective Market Report

Report Metric Details
Report Name Drugs for Anti-Infective Market
Accounted market size in 2023 US$ 215340 million
Forecasted market size in 2030 US$ 272130 million
CAGR 3.4%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • OTC
  • Rx Drugs
Segment by Application
  • Hospital
  • Drugs Store
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GlaxoSmithKline, Merck, Pfizer, Novartis AG, Gilead Sciences, Abbott, Sanofi-Aventis, Bristol-Myers Squibb, Johnson, Roche Pharma AG, Nanosphere, NanoViricides, Novabay Pharmaceuticals, Obetech, Optimer Pharmaceuticals, Basilea Pharmaceutica AG, Daiichi Sankyo
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Drugs for Anti-Infective companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Drugs for Anti-Infective Market growing?

Ans: The Drugs for Anti-Infective Market witnessing a CAGR of 3.4% during the forecast period 2024-2030.

What is the Drugs for Anti-Infective Market size in 2030?

Ans: The Drugs for Anti-Infective Market size in 2030 will be US$ 272130 million.

Who are the main players in the Drugs for Anti-Infective Market report?

Ans: The main players in the Drugs for Anti-Infective Market are GlaxoSmithKline, Merck, Pfizer, Novartis AG, Gilead Sciences, Abbott, Sanofi-Aventis, Bristol-Myers Squibb, Johnson, Roche Pharma AG, Nanosphere, NanoViricides, Novabay Pharmaceuticals, Obetech, Optimer Pharmaceuticals, Basilea Pharmaceutica AG, Daiichi Sankyo

What are the Application segmentation covered in the Drugs for Anti-Infective Market report?

Ans: The Applications covered in the Drugs for Anti-Infective Market report are Hospital, Drugs Store, Other

What are the Type segmentation covered in the Drugs for Anti-Infective Market report?

Ans: The Types covered in the Drugs for Anti-Infective Market report are OTC, Rx Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs for Anti-Infective Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Market by Application
1.3.1 Global Drugs for Anti-Infective Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drugs for Anti-Infective Market Perspective (2019-2030)
2.2 Drugs for Anti-Infective Growth Trends by Region
2.2.1 Global Drugs for Anti-Infective Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drugs for Anti-Infective Historic Market Size by Region (2019-2024)
2.2.3 Drugs for Anti-Infective Forecasted Market Size by Region (2025-2030)
2.3 Drugs for Anti-Infective Market Dynamics
2.3.1 Drugs for Anti-Infective Industry Trends
2.3.2 Drugs for Anti-Infective Market Drivers
2.3.3 Drugs for Anti-Infective Market Challenges
2.3.4 Drugs for Anti-Infective Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drugs for Anti-Infective Players by Revenue
3.1.1 Global Top Drugs for Anti-Infective Players by Revenue (2019-2024)
3.1.2 Global Drugs for Anti-Infective Revenue Market Share by Players (2019-2024)
3.2 Global Drugs for Anti-Infective Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drugs for Anti-Infective Revenue
3.4 Global Drugs for Anti-Infective Market Concentration Ratio
3.4.1 Global Drugs for Anti-Infective Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs for Anti-Infective Revenue in 2023
3.5 Drugs for Anti-Infective Key Players Head office and Area Served
3.6 Key Players Drugs for Anti-Infective Product Solution and Service
3.7 Date of Enter into Drugs for Anti-Infective Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs for Anti-Infective Breakdown Data by Type
4.1 Global Drugs for Anti-Infective Historic Market Size by Type (2019-2024)
4.2 Global Drugs for Anti-Infective Forecasted Market Size by Type (2025-2030)
5 Drugs for Anti-Infective Breakdown Data by Application
5.1 Global Drugs for Anti-Infective Historic Market Size by Application (2019-2024)
5.2 Global Drugs for Anti-Infective Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Drugs for Anti-Infective Market Size (2019-2030)
6.2 North America Drugs for Anti-Infective Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Drugs for Anti-Infective Market Size by Country (2019-2024)
6.4 North America Drugs for Anti-Infective Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drugs for Anti-Infective Market Size (2019-2030)
7.2 Europe Drugs for Anti-Infective Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Drugs for Anti-Infective Market Size by Country (2019-2024)
7.4 Europe Drugs for Anti-Infective Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drugs for Anti-Infective Market Size (2019-2030)
8.2 Asia-Pacific Drugs for Anti-Infective Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Drugs for Anti-Infective Market Size by Region (2019-2024)
8.4 Asia-Pacific Drugs for Anti-Infective Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drugs for Anti-Infective Market Size (2019-2030)
9.2 Latin America Drugs for Anti-Infective Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Drugs for Anti-Infective Market Size by Country (2019-2024)
9.4 Latin America Drugs for Anti-Infective Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drugs for Anti-Infective Market Size (2019-2030)
10.2 Middle East & Africa Drugs for Anti-Infective Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Drugs for Anti-Infective Market Size by Country (2019-2024)
10.4 Middle East & Africa Drugs for Anti-Infective Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Drugs for Anti-Infective Introduction
11.1.4 GlaxoSmithKline Revenue in Drugs for Anti-Infective Business (2019-2024)
11.1.5 GlaxoSmithKline Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Drugs for Anti-Infective Introduction
11.2.4 Merck Revenue in Drugs for Anti-Infective Business (2019-2024)
11.2.5 Merck Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Drugs for Anti-Infective Introduction
11.3.4 Pfizer Revenue in Drugs for Anti-Infective Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Detail
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Drugs for Anti-Infective Introduction
11.4.4 Novartis AG Revenue in Drugs for Anti-Infective Business (2019-2024)
11.4.5 Novartis AG Recent Development
11.5 Gilead Sciences
11.5.1 Gilead Sciences Company Detail
11.5.2 Gilead Sciences Business Overview
11.5.3 Gilead Sciences Drugs for Anti-Infective Introduction
11.5.4 Gilead Sciences Revenue in Drugs for Anti-Infective Business (2019-2024)
11.5.5 Gilead Sciences Recent Development
11.6 Abbott
11.6.1 Abbott Company Detail
11.6.2 Abbott Business Overview
11.6.3 Abbott Drugs for Anti-Infective Introduction
11.6.4 Abbott Revenue in Drugs for Anti-Infective Business (2019-2024)
11.6.5 Abbott Recent Development
11.7 Sanofi-Aventis
11.7.1 Sanofi-Aventis Company Detail
11.7.2 Sanofi-Aventis Business Overview
11.7.3 Sanofi-Aventis Drugs for Anti-Infective Introduction
11.7.4 Sanofi-Aventis Revenue in Drugs for Anti-Infective Business (2019-2024)
11.7.5 Sanofi-Aventis Recent Development
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Detail
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Drugs for Anti-Infective Introduction
11.8.4 Bristol-Myers Squibb Revenue in Drugs for Anti-Infective Business (2019-2024)
11.8.5 Bristol-Myers Squibb Recent Development
11.9 Johnson
11.9.1 Johnson Company Detail
11.9.2 Johnson Business Overview
11.9.3 Johnson Drugs for Anti-Infective Introduction
11.9.4 Johnson Revenue in Drugs for Anti-Infective Business (2019-2024)
11.9.5 Johnson Recent Development
11.10 Roche Pharma AG
11.10.1 Roche Pharma AG Company Detail
11.10.2 Roche Pharma AG Business Overview
11.10.3 Roche Pharma AG Drugs for Anti-Infective Introduction
11.10.4 Roche Pharma AG Revenue in Drugs for Anti-Infective Business (2019-2024)
11.10.5 Roche Pharma AG Recent Development
11.11 Nanosphere
11.11.1 Nanosphere Company Detail
11.11.2 Nanosphere Business Overview
11.11.3 Nanosphere Drugs for Anti-Infective Introduction
11.11.4 Nanosphere Revenue in Drugs for Anti-Infective Business (2019-2024)
11.11.5 Nanosphere Recent Development
11.12 NanoViricides
11.12.1 NanoViricides Company Detail
11.12.2 NanoViricides Business Overview
11.12.3 NanoViricides Drugs for Anti-Infective Introduction
11.12.4 NanoViricides Revenue in Drugs for Anti-Infective Business (2019-2024)
11.12.5 NanoViricides Recent Development
11.13 Novabay Pharmaceuticals
11.13.1 Novabay Pharmaceuticals Company Detail
11.13.2 Novabay Pharmaceuticals Business Overview
11.13.3 Novabay Pharmaceuticals Drugs for Anti-Infective Introduction
11.13.4 Novabay Pharmaceuticals Revenue in Drugs for Anti-Infective Business (2019-2024)
11.13.5 Novabay Pharmaceuticals Recent Development
11.14 Obetech
11.14.1 Obetech Company Detail
11.14.2 Obetech Business Overview
11.14.3 Obetech Drugs for Anti-Infective Introduction
11.14.4 Obetech Revenue in Drugs for Anti-Infective Business (2019-2024)
11.14.5 Obetech Recent Development
11.15 Optimer Pharmaceuticals
11.15.1 Optimer Pharmaceuticals Company Detail
11.15.2 Optimer Pharmaceuticals Business Overview
11.15.3 Optimer Pharmaceuticals Drugs for Anti-Infective Introduction
11.15.4 Optimer Pharmaceuticals Revenue in Drugs for Anti-Infective Business (2019-2024)
11.15.5 Optimer Pharmaceuticals Recent Development
11.16 Basilea Pharmaceutica AG
11.16.1 Basilea Pharmaceutica AG Company Detail
11.16.2 Basilea Pharmaceutica AG Business Overview
11.16.3 Basilea Pharmaceutica AG Drugs for Anti-Infective Introduction
11.16.4 Basilea Pharmaceutica AG Revenue in Drugs for Anti-Infective Business (2019-2024)
11.16.5 Basilea Pharmaceutica AG Recent Development
11.17 Daiichi Sankyo
11.17.1 Daiichi Sankyo Company Detail
11.17.2 Daiichi Sankyo Business Overview
11.17.3 Daiichi Sankyo Drugs for Anti-Infective Introduction
11.17.4 Daiichi Sankyo Revenue in Drugs for Anti-Infective Business (2019-2024)
11.17.5 Daiichi Sankyo Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Drugs for Anti-Infective Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of OTC
    Table 3. Key Players of Rx Drugs
    Table 4. Global Drugs for Anti-Infective Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 5. Global Drugs for Anti-Infective Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Drugs for Anti-Infective Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Drugs for Anti-Infective Market Share by Region (2019-2024)
    Table 8. Global Drugs for Anti-Infective Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Drugs for Anti-Infective Market Share by Region (2025-2030)
    Table 10. Drugs for Anti-Infective Market Trends
    Table 11. Drugs for Anti-Infective Market Drivers
    Table 12. Drugs for Anti-Infective Market Challenges
    Table 13. Drugs for Anti-Infective Market Restraints
    Table 14. Global Drugs for Anti-Infective Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Drugs for Anti-Infective Market Share by Players (2019-2024)
    Table 16. Global Top Drugs for Anti-Infective Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Anti-Infective as of 2023)
    Table 17. Ranking of Global Top Drugs for Anti-Infective Companies by Revenue (US$ Million) in 2023
    Table 18. Global 5 Largest Players Market Share by Drugs for Anti-Infective Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Drugs for Anti-Infective Product Solution and Service
    Table 21. Date of Enter into Drugs for Anti-Infective Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Drugs for Anti-Infective Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Drugs for Anti-Infective Revenue Market Share by Type (2019-2024)
    Table 25. Global Drugs for Anti-Infective Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Drugs for Anti-Infective Revenue Market Share by Type (2025-2030)
    Table 27. Global Drugs for Anti-Infective Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Drugs for Anti-Infective Revenue Market Share by Application (2019-2024)
    Table 29. Global Drugs for Anti-Infective Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Drugs for Anti-Infective Revenue Market Share by Application (2025-2030)
    Table 31. North America Drugs for Anti-Infective Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 32. North America Drugs for Anti-Infective Market Size by Country (2019-2024) & (US$ Million)
    Table 33. North America Drugs for Anti-Infective Market Size by Country (2025-2030) & (US$ Million)
    Table 34. Europe Drugs for Anti-Infective Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. Europe Drugs for Anti-Infective Market Size by Country (2019-2024) & (US$ Million)
    Table 36. Europe Drugs for Anti-Infective Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Asia-Pacific Drugs for Anti-Infective Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Asia-Pacific Drugs for Anti-Infective Market Size by Region (2019-2024) & (US$ Million)
    Table 39. Asia-Pacific Drugs for Anti-Infective Market Size by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Drugs for Anti-Infective Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Latin America Drugs for Anti-Infective Market Size by Country (2019-2024) & (US$ Million)
    Table 42. Latin America Drugs for Anti-Infective Market Size by Country (2025-2030) & (US$ Million)
    Table 43. Middle East & Africa Drugs for Anti-Infective Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Middle East & Africa Drugs for Anti-Infective Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Middle East & Africa Drugs for Anti-Infective Market Size by Country (2025-2030) & (US$ Million)
    Table 46. GlaxoSmithKline Company Detail
    Table 47. GlaxoSmithKline Business Overview
    Table 48. GlaxoSmithKline Drugs for Anti-Infective Product
    Table 49. GlaxoSmithKline Revenue in Drugs for Anti-Infective Business (2019-2024) & (US$ Million)
    Table 50. GlaxoSmithKline Recent Development
    Table 51. Merck Company Detail
    Table 52. Merck Business Overview
    Table 53. Merck Drugs for Anti-Infective Product
    Table 54. Merck Revenue in Drugs for Anti-Infective Business (2019-2024) & (US$ Million)
    Table 55. Merck Recent Development
    Table 56. Pfizer Company Detail
    Table 57. Pfizer Business Overview
    Table 58. Pfizer Drugs for Anti-Infective Product
    Table 59. Pfizer Revenue in Drugs for Anti-Infective Business (2019-2024) & (US$ Million)
    Table 60. Pfizer Recent Development
    Table 61. Novartis AG Company Detail
    Table 62. Novartis AG Business Overview
    Table 63. Novartis AG Drugs for Anti-Infective Product
    Table 64. Novartis AG Revenue in Drugs for Anti-Infective Business (2019-2024) & (US$ Million)
    Table 65. Novartis AG Recent Development
    Table 66. Gilead Sciences Company Detail
    Table 67. Gilead Sciences Business Overview
    Table 68. Gilead Sciences Drugs for Anti-Infective Product
    Table 69. Gilead Sciences Revenue in Drugs for Anti-Infective Business (2019-2024) & (US$ Million)
    Table 70. Gilead Sciences Recent Development
    Table 71. Abbott Company Detail
    Table 72. Abbott Business Overview
    Table 73. Abbott Drugs for Anti-Infective Product
    Table 74. Abbott Revenue in Drugs for Anti-Infective Business (2019-2024) & (US$ Million)
    Table 75. Abbott Recent Development
    Table 76. Sanofi-Aventis Company Detail
    Table 77. Sanofi-Aventis Business Overview
    Table 78. Sanofi-Aventis Drugs for Anti-Infective Product
    Table 79. Sanofi-Aventis Revenue in Drugs for Anti-Infective Business (2019-2024) & (US$ Million)
    Table 80. Sanofi-Aventis Recent Development
    Table 81. Bristol-Myers Squibb Company Detail
    Table 82. Bristol-Myers Squibb Business Overview
    Table 83. Bristol-Myers Squibb Drugs for Anti-Infective Product
    Table 84. Bristol-Myers Squibb Revenue in Drugs for Anti-Infective Business (2019-2024) & (US$ Million)
    Table 85. Bristol-Myers Squibb Recent Development
    Table 86. Johnson Company Detail
    Table 87. Johnson Business Overview
    Table 88. Johnson Drugs for Anti-Infective Product
    Table 89. Johnson Revenue in Drugs for Anti-Infective Business (2019-2024) & (US$ Million)
    Table 90. Johnson Recent Development
    Table 91. Roche Pharma AG Company Detail
    Table 92. Roche Pharma AG Business Overview
    Table 93. Roche Pharma AG Drugs for Anti-Infective Product
    Table 94. Roche Pharma AG Revenue in Drugs for Anti-Infective Business (2019-2024) & (US$ Million)
    Table 95. Roche Pharma AG Recent Development
    Table 96. Nanosphere Company Detail
    Table 97. Nanosphere Business Overview
    Table 98. Nanosphere Drugs for Anti-Infective Product
    Table 99. Nanosphere Revenue in Drugs for Anti-Infective Business (2019-2024) & (US$ Million)
    Table 100. Nanosphere Recent Development
    Table 101. NanoViricides Company Detail
    Table 102. NanoViricides Business Overview
    Table 103. NanoViricides Drugs for Anti-Infective Product
    Table 104. NanoViricides Revenue in Drugs for Anti-Infective Business (2019-2024) & (US$ Million)
    Table 105. NanoViricides Recent Development
    Table 106. Novabay Pharmaceuticals Company Detail
    Table 107. Novabay Pharmaceuticals Business Overview
    Table 108. Novabay Pharmaceuticals Drugs for Anti-Infective Product
    Table 109. Novabay Pharmaceuticals Revenue in Drugs for Anti-Infective Business (2019-2024) & (US$ Million)
    Table 110. Novabay Pharmaceuticals Recent Development
    Table 111. Obetech Company Detail
    Table 112. Obetech Business Overview
    Table 113. Obetech Drugs for Anti-Infective Product
    Table 114. Obetech Revenue in Drugs for Anti-Infective Business (2019-2024) & (US$ Million)
    Table 115. Obetech Recent Development
    Table 116. Optimer Pharmaceuticals Company Detail
    Table 117. Optimer Pharmaceuticals Business Overview
    Table 118. Optimer Pharmaceuticals Drugs for Anti-Infective Product
    Table 119. Optimer Pharmaceuticals Revenue in Drugs for Anti-Infective Business (2019-2024) & (US$ Million)
    Table 120. Optimer Pharmaceuticals Recent Development
    Table 121. Basilea Pharmaceutica AG Company Detail
    Table 122. Basilea Pharmaceutica AG Business Overview
    Table 123. Basilea Pharmaceutica AG Drugs for Anti-Infective Product
    Table 124. Basilea Pharmaceutica AG Revenue in Drugs for Anti-Infective Business (2019-2024) & (US$ Million)
    Table 125. Basilea Pharmaceutica AG Recent Development
    Table 126. Daiichi Sankyo Company Detail
    Table 127. Daiichi Sankyo Business Overview
    Table 128. Daiichi Sankyo Drugs for Anti-Infective Product
    Table 129. Daiichi Sankyo Revenue in Drugs for Anti-Infective Business (2019-2024) & (US$ Million)
    Table 130. Daiichi Sankyo Recent Development
    Table 131. Research Programs/Design for This Report
    Table 132. Key Data Information from Secondary Sources
    Table 133. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Drugs for Anti-Infective Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Drugs for Anti-Infective Market Share by Type: 2023 VS 2030
    Figure 3. OTC Features
    Figure 4. Rx Drugs Features
    Figure 5. Global Drugs for Anti-Infective Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 6. Global Drugs for Anti-Infective Market Share by Application: 2023 VS 2030
    Figure 7. Hospital Case Studies
    Figure 8. Drugs Store Case Studies
    Figure 9. Other Case Studies
    Figure 10. Drugs for Anti-Infective Report Years Considered
    Figure 11. Global Drugs for Anti-Infective Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global Drugs for Anti-Infective Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Drugs for Anti-Infective Market Share by Region: 2023 VS 2030
    Figure 14. Global Drugs for Anti-Infective Market Share by Players in 2023
    Figure 15. Global Top Drugs for Anti-Infective Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Anti-Infective as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by Drugs for Anti-Infective Revenue in 2023
    Figure 17. North America Drugs for Anti-Infective Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America Drugs for Anti-Infective Market Share by Country (2019-2030)
    Figure 19. United States Drugs for Anti-Infective Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. Canada Drugs for Anti-Infective Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Europe Drugs for Anti-Infective Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe Drugs for Anti-Infective Market Share by Country (2019-2030)
    Figure 23. Germany Drugs for Anti-Infective Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. France Drugs for Anti-Infective Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. U.K. Drugs for Anti-Infective Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Italy Drugs for Anti-Infective Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Russia Drugs for Anti-Infective Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Nordic Countries Drugs for Anti-Infective Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Asia-Pacific Drugs for Anti-Infective Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Asia-Pacific Drugs for Anti-Infective Market Share by Region (2019-2030)
    Figure 31. China Drugs for Anti-Infective Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Japan Drugs for Anti-Infective Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. South Korea Drugs for Anti-Infective Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Southeast Asia Drugs for Anti-Infective Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. India Drugs for Anti-Infective Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Australia Drugs for Anti-Infective Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Latin America Drugs for Anti-Infective Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Latin America Drugs for Anti-Infective Market Share by Country (2019-2030)
    Figure 39. Mexico Drugs for Anti-Infective Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Brazil Drugs for Anti-Infective Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Middle East & Africa Drugs for Anti-Infective Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Middle East & Africa Drugs for Anti-Infective Market Share by Country (2019-2030)
    Figure 43. Turkey Drugs for Anti-Infective Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Saudi Arabia Drugs for Anti-Infective Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. GlaxoSmithKline Revenue Growth Rate in Drugs for Anti-Infective Business (2019-2024)
    Figure 46. Merck Revenue Growth Rate in Drugs for Anti-Infective Business (2019-2024)
    Figure 47. Pfizer Revenue Growth Rate in Drugs for Anti-Infective Business (2019-2024)
    Figure 48. Novartis AG Revenue Growth Rate in Drugs for Anti-Infective Business (2019-2024)
    Figure 49. Gilead Sciences Revenue Growth Rate in Drugs for Anti-Infective Business (2019-2024)
    Figure 50. Abbott Revenue Growth Rate in Drugs for Anti-Infective Business (2019-2024)
    Figure 51. Sanofi-Aventis Revenue Growth Rate in Drugs for Anti-Infective Business (2019-2024)
    Figure 52. Bristol-Myers Squibb Revenue Growth Rate in Drugs for Anti-Infective Business (2019-2024)
    Figure 53. Johnson Revenue Growth Rate in Drugs for Anti-Infective Business (2019-2024)
    Figure 54. Roche Pharma AG Revenue Growth Rate in Drugs for Anti-Infective Business (2019-2024)
    Figure 55. Nanosphere Revenue Growth Rate in Drugs for Anti-Infective Business (2019-2024)
    Figure 56. NanoViricides Revenue Growth Rate in Drugs for Anti-Infective Business (2019-2024)
    Figure 57. Novabay Pharmaceuticals Revenue Growth Rate in Drugs for Anti-Infective Business (2019-2024)
    Figure 58. Obetech Revenue Growth Rate in Drugs for Anti-Infective Business (2019-2024)
    Figure 59. Optimer Pharmaceuticals Revenue Growth Rate in Drugs for Anti-Infective Business (2019-2024)
    Figure 60. Basilea Pharmaceutica AG Revenue Growth Rate in Drugs for Anti-Infective Business (2019-2024)
    Figure 61. Daiichi Sankyo Revenue Growth Rate in Drugs for Anti-Infective Business (2019-2024)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Pharmaceutical Aseptic Fill and Finish CMO Service Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-1R8980
Tue Feb 20 00:00:00 UTC 2024

Add to Cart

Global Quizartinib Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-3Q8625
Tue Feb 20 00:00:00 UTC 2024

Add to Cart

Global Octreotide Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-3X12361
Tue Feb 20 00:00:00 UTC 2024

Add to Cart

Global Veterinary Anesthesia Vaporizers Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-35M13226
Tue Feb 20 00:00:00 UTC 2024

Add to Cart